iShares MBS ETF vs Vital Farms Inc — how do they compare? iShares MBS ETF trades at $89.79 (market cap $35.41B), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: iShares MBS ETF is far larger — about 87.4× Vital Farms Inc's market cap, and iShares MBS ETF is more actively traded (5,388,525 versus 1,810,837). Which is the better fit depends on your goals — on Pluang, investors hold iShares MBS ETF for 96 Days and Vital Farms Inc for 14 Days on average.
| MBB | VITL | |
|---|---|---|
Market Cap | $35.41B | $405.27M |
Volume | 5,388,525 | 1,810,837 |
Sector | Fixed Income | Consumer Staples |
52-Week High | $96.91 | $43.40 |
52-Week Low | $89.09 | $8.28 |
Typical Hold Time | 96 Days | 14 Days |
Enterprise Value | — | $492.28M |
Signals from Pluang's Aura AI — not financial advice
MBB (iShares MBS ETF) trades at $89.73 with a slight 0.57% daily gain, though technical indicators signal bearish momentum with moving averages and ADX both in sell territory. The ETF recently hit a 52-week low of $91.02 in September 2026, reflecting pressure from rising intermediate-term rates and inflation concerns. Recent institutional activity shows mixed sentiment, with Corient Private Wealth increasing its position by 28.3% while short interest surged 98.3% to 6.57 million shares as of September 15, 2026.
The outlook remains cautious due to interest rate sensitivity and convexity risk in mortgage-backed securities. While Norway's $2.3 trillion sovereign wealth fund rotation into MBS provides institutional support, the intermediate duration of 5.68 years exposes MBB to Fed policy uncertainty. Key risks include persistent inflation and borrower prepayment behavior limiting upside potential.
Vital Farms (VITL) trades at $9.435, up 2.11% today, amid a challenging period marked by volatile earnings and a bearish technical signal. The stock shows weak profitability with a net income margin of 0.02% in 2026, though valuation ratios like P/S of 0.55 appear attractive. Recent news highlights strategic review for a potential sale, with price targets ranging from $10 to $20. Cash flow remains negative, driven by heavy investing activities, while institutional interest persists with new acquisitions.
The outlook is mixed: analyst consensus is bullish with a $13.11 target, but near-term risks include pricing pressure in the egg market and earnings volatility. Recovery hinges on stabilizing supply costs and executing strategic options. Investors should weigh low valuation against operational challenges and industry headwinds for potential upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →